|Bid||0.0000 x 21500|
|Ask||0.0000 x 1800|
|Day's range||2.5900 - 2.6900|
|52-week range||1.0100 - 6.4500|
|Beta (5Y monthly)||1.44|
|PE ratio (TTM)||N/A|
|Earnings date||19 Jul 2021 - 23 Jul 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
It's safe to say that few expected a blowout third quarter from this relatively low-key New Brunswick operator.
As of 2 p.m. EDT Thursday, shares of marijuana stocks Hexo (NYSE: HEXO), OrganiGram Holdings (NASDAQ: OGI), Tilray (NASDAQ: TLRY), and Sundial Growers (NASDAQ: SNDL) are all sliding, down 4.7%, 2.6%, 2.4%, and 1.6%, respectively -- and the reason appears to be marijuana legalization. In a column this morning, the Los Angeles Times laid out the facts about the marijuana legalization bill soon to be introduced for consideration by the U.S. Senate. As the paper reports, the draft Cannabis Administration and Opportunity Act promises to decriminalize marijuana sale, possession, and use, clear the criminal records of "nonviolent offenders of federal cannabis laws," and "formally" recognize that states can decide for themselves whether or not to legalize pot.
Canadian cannabis company OrganiGram Holdings (NASDAQ: OGI) hasn't been a great growth investment over the past year. OrganiGram highlighted impressive quarter-over-quarter revenue growth of 51% when it reported its third-quarter results. Net revenue of CA$20.3 million was up by 39% from the previous quarter.